Drug application
PSEUDO-12 (PSEUDOEPHEDRINE POLISTIREX)
Drugs@FDA NDA 019401 · UCB INC
Key facts
| Drug name | PSEUDO-12 |
|---|---|
| Active ingredients | PSEUDOEPHEDRINE POLISTIREX |
| Application type | NDA |
| Application number | 019401 |
| Company | UCB INC |
| Dosage forms | SUSPENSION, EXTENDED RELEASE, ORAL |
| Strength | EQ 60MG HYDROCHLORIDE/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 2 - New Active Ingredient and Type 3 - New Dosage Form |
| Latest submission status date | Jun 19, 1987 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.